Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|August 13, 2011
Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patientsLoubna Jouan, Laurent Chatel-Chaix, Pierre Melançon, et al.
Blood|June 14, 2003
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicinCarlos J Miranda, Hortence Makui, Ricardo J Soares, et al.
Annals of Hepatology|August 26, 2014
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experienceNabiha Faisal, Eric M Yoshida, Marc Bilodeau, et al.
Plos One|June 15, 2018
Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemiaTom S Chan, Shamir Cassim, Valérie-Ann Raymond, et al.
Canadian Liver Journal|July 18, 2025
Evolving trends in liver transplantation eligibility: A shift toward inclusivity for older adults at a Canadian Transplant CenterGabrielle Jutras, Genevieve Huard, Marc Bilodeau, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 6, 2018
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective StudyNabiha Faisal, Marc Bilodeau, Bandar Aljudaibi, et al.
Annals of Hepatology|May 9, 2018
Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National ExperienceBandar Al-Judaibi, Benson Thomas, Philip Wong, et al.
Cancer Research|July 2, 2020
Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 DeficiencyChi Luo, Jiaxin Liang, Kfir Sharabi, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 15, 2022
Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related FibrosisMohamed N Abdelnabi, Manuel Flores Molina, Geneviève Soucy, et al.
Clinical Transplantation|March 8, 2021
Non-invasive diagnostic imaging tests largely underdiagnose cardiac cirrhosis in patients undergoing advanced therapy evaluation: How can we identify the high-risk patient?David Belzile, Pierre Yves Turgeon, Evelyne Leblanc, et al.
Pageof 7